News - NovaDel Pharma


Current filters:

NovaDel Pharma

Popular Filters

US FDA lowers recommended dose for sleep drugs containing zolpidem


The US Food and Drug Administration yesterday announced it is requiring the manufacturers of Ambien,…

AmbienAmbien CREdluarMedaNeurologicalNorth AmericaNovaDel PharmaPharmaceuticalRegulationSanofizolpidemZolpiMist

NovaDel regains rights for ondansetron oral spray product


New Jersey, USA-based NovaDel Pharma (OTCBB: NVDL) has announced the termination of certain license agreements…

BioAlliance PharmaLicensingNovaDel PharmaOncologyondansetronPar PharmaceuticalPharmaceuticalTalon Therapeutics

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top